NSECertificate under SEBI (Depositories and Participants) Regulations, 20189 Oct 2026 · 9 Oct 2026, 11:25 am
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Venus Remedies Limited · VENUSREM
✦ AI SummaryRegulatory
Venus Remedies Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018, confirming the securities received for dematerialization during the quarter ended 30th September 2026.
Analysis Scores
Earnings Impact1/10
Growth Catalyst1/10
Governance Concern1/10
Regulatory Risk2/10
Balance Sheet Risk1/10
Liquidity Impact1/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Venus Remedies Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
Attachments (1)
📄pdf
Download →
VENUSREM_09102026112508_Reg_74_comp_Sep2026_VRL.pdf
View document text
VENUS
6nioy g nnoualions
VRL/SEC/EXCHANGE 09.10.2026
National Stock Exchange of India BSE Limited
Ltd.
25th Floor, Phiprinceroze Jeejeebhoy
5th Floor, Exchange Plaza
Towers, Dalal Street
Bandra (E),
Mumbai
Mumbai- 400 051
Script Code: 526953
Script Code: VENUSREM
Sub.: Compliance under Regulatjon74(5) of SEBl (Depositories and Participants)
Regulations.2018.
Dear Sir/ Madam,
In compliance with Regulation 74(5) of Securities and Exchange Board of India (Depositories
and Participants) Regulation, 2018, we enclose herewith Confirmation Certificate received
from our Registrar & Transfer Agent, M/s MUFG lntime India Pvt Ltd. for the quarter ended
on 30th September 2026.
Thanking you
Yours faithfully,
for VENUS REMEDIES LIMITED
Neha
(Company Secretary)
M. No. F8374
VENUS REMEDIES LIMITED
Corponte Omc. : Uult-I :
51 -52, Industrial Area, Phase-I, Panchkula (Hry.)
i:i-.5.2;5T9]u7S2r233t886?gssc3'6'9ETFC±ku+[gfT]72)_23€;!3'6'nd`a
1341 13 , India
Reed. once : Ualt-II :
SCO 857, Cabin No. 10, 2nd Floor, NAG, Manimajra,
Chandigarh (U.T.) 160101, India ¥ei;i°I##9S':g294d28isi#;;2f?¥oa!:]E:::'Phase'HExtn.)
Website . www.venusremedies.com
www.vmrcindia.com Uult-V :
VENUS PHARMA GmbH ©#"ETgs
en¥JL2¥ffiENfse8EL€tw7o5 AM Bahnhof 1-3, D-59368,
Weme, Germany
©MUFG MUFC Intlm. lhdl. P.lv.I. Llrnltnd
(Formerly Lirik lntimo India Private Lini(ed)
ciN: ue7icoNHie.9pTci ie3ce
Noble Hoight§. 1 8t toor, Plot No NH-2,
C.1 Block. LSC. N®ai S®vtm Mark®t.
Janakpuri. Nour Delhi -11cO58.
T.I: +91 11 4941 1000
vw.in.mpm8.mufg.com
Octofror 7, 2o26
The Company Secrofary
Venue Ronedles llmltod
SCO e57, cABiN NO io ,
2NO FLOOR, MAC, MANIMAJRA
Chandl8arh -160101.
Dear Sir.
?_|irm caTqurm e!rftqu led:r Ft.au+.tlon 74(!\ Of amrftha .nd E]tchmn ~_Of
d Partlc
ln reference to the above captioned regulation. we hereby confirm that the securities received from the
depository participants for dematerialization during the qiiarter ended 3On September 2026, were
confirmed (accepted/rejected) to the depositories by us and that securities comprised in the said
certificates have been listed on the stock exchanges where the earlier issued secu ties are listed.
ve hereby also confirm that the §®curity certificates received for dematerialisation have been
confined/rejected and the security certificates received were mutilated and cancelled after due
verificatl.on by the depository participant and the name of the depositories have bcon substituted in the
register of members as the registered owner within the prescribed timoljnes. We request you to kindly
take note of the above in your records.
Thanklng You,
Youn falthfully.
Foi MUFG Intlm® lndla Prlv.t® Llmlt®d
(Fomerly Llnk lntlme India Private Llmlt®d)
. .i._.' -.-- i -.
Swapan Kr Nas
Asooclate Vi a Head (Delhl Branch)
MUFG Intlme lndl. PTlvat. umked
A part of MUFG Corporate Markets, 3 division of MUFG Pension & Market Services